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Meditation is a popular practice for reducing stress and improving mental health and wellbeing. Its 38 
effects are mediated largely by the endocrine system, including the hypothalamic–pituitary–adrenal 39 
axis, the hypothalamic–pituitary–thyroid axis and the renin-angiotensin-aldosterone system, and 40 
energy homeostasis. The limited evidence available indicates that changes associated with 41 
endocrine function following meditation correspond with improvements in mental health. However, 42 
this field of study is hampered by a lack of consensus as to definition and types of meditation and 43 
the mixed quality of reported studies. Moreover, the exact mechanisms by which meditation 44 
operates remain unclear and more robust studies are required to explore this by delineating the 45 
target populations, forms, dosages and modes of delivery of meditation, comparison groups, and 46 





There is increasing interest in the practice of meditation and its effects on physiological markers of 52 
stress, meditated largely by the endocrine system, though the precise links and mechanisms by 53 
which these occur remain unclear.  54 
 55 
Most studies have investigated the effects of meditation practice on the hypothalamic–pituitary–56 
adrenal axis, with comparatively little attention paid to other parts of the endocrine system. 57 
 58 
Growing but limited evidence indicates that changes associated with endocrine function after 59 
meditation may correspond with improvements in mental health outcomes, but more robust 60 







Adrenocorticotropin hormone: A polypeptide tropic hormone that is an important component of the 66 
hypothalamic-pituitary-adrenal axis and is often produced in response to biological stress 67 
Corticotropin-releasing hormone: A peptide hormone involved in the stress response 68 
Cortisol: A glucocorticoid hormone widely used biomarker of HPA axis dysfunction 69 
Endocrine system: A number of glands that produce hormones which regulate many functions in the 70 
body and is important in managing and responding to stress 71 
Hypothalamic–Pituitary–Adrenal (HPA) Axis: A neuroendocrine system that controls reactions to 72 
stress and regulates many body processes 73 
Hypothalamic–Pituitary–Thyroid (HPT) Axis: An endocrine system that regulates thyroid hormone 74 
production 75 
Insulin: A peptide hormone necessary for the control of blood glucose  76 
Leptin: A hormone secreted by and in proportion to adipose cells and regulates energy by inhibiting 77 
hunger 78 
Meditation: Practices and techniques, such as mindfulness, transcendental meditation, and breath 79 
awareness that encourage and develop concentration, clarity, emotional positivity and a cultivation 80 
of non-judgmental awareness 81 
Renin-Angiotensin-Aldosterone (RAA) System: An endocrine system that regulates blood pressure, 82 
electrolyte and fluid balance 83 
Stress: A disruption to homeostasis and stressor-induced activation of the sympathetic nervous 84 








Meditation Influences the Stress Response 91 
Meditation, which has its origins in India and dates as far back as 5000 BCE, has become increasingly 92 
popular and widely practiced as a secular and therapeutic activity [1]. The word meditation stems 93 
from meditatum, a Latin term ‘to ponder’. Meditation practices are techniques, such as mindfulness, 94 
transcendental meditation, and breath awareness that encourage and develop concentration, 95 
clarity, emotional positivity and a cultivation of non-judgmental awareness [2, 3]. Various forms – 96 
spiritual and secular - of meditation have been developed, with the latter emphasizing stress 97 
reduction and relaxation [4]. However, the term meditation has been used to designate a variety of 98 
practices that differ enough from each other that they elude precise definition [4], and the lack of 99 
consensus in defining meditation has hampered its acceptance for study in the scientific community. 100 
Nevertheless, research on meditation has increased dramatically over the last 50 years. Studies in 101 
the West have explored the impact of meditation on mental and physiological outcomes, and 102 
though the exact mechanisms at work remain elusive there is evidence that following meditation 103 
changes are seen in brain structure and function e.g. thickening of the cerebral cortex, lower 104 
frequency alpha and theta waves [5-7], physiological markers of stress e.g. lower blood cortisol 105 
levels, slower respiratory rate [8, 9] and cardiovascular risk factors e.g. lower blood pressure and 106 
heart rate [10], mediated largely by the endocrine system and in response to stressors.  107 
 108 
The Endocrine System and Stress  109 
The endocrine system comprises a number of glands – the hypothalamus, pituitary gland and pineal 110 
gland in the brain, the thyroid and parathyroid glands in the neck, the thymus in between the lungs, 111 
the adrenal glands on top of the kidneys, the pancreas behind the stomach and the gonads in the 112 
pelvic region - that produce hormones which regulate many functions in the body and is important 113 
in managing and responding to stress. It is a chemical messenger system comprising of feedback 114 
loops regulated by hormones released by glands into the circulatory system to regulate distant 115 




Stress can be defined as disruption to homeostasis and activation of the stress response, or ‘fight-or-118 
flight’ response. Humans, as with all living things, maintain a dynamic equilibrium – homeostasis – 119 
which is the stable state or balance of the organism and of optimal functioning. Humans are also 120 
constantly challenged by internal or external stressors, which can be real or perceived threats to 121 
homeostasis (or safety or wellbeing) and result in adaptive physiological and metabolic changes that 122 
maximise chances of surviving these threats [12]. This stress response is mainly regulated by the 123 
central nervous system through activation of the sympathetic and parasympathetic divisions of the 124 
autonomic nervous system and actions of neuro-humoral mediators such as the hypothalamic-125 
pituitary-adrenal axis and the catecholaminergic system [13]. This includes increases in heart rate 126 
and blood pressure to send oxygen to muscles, pupil dilation to let in as much light as possible, and 127 
the downstream release of the glucocorticoid hormone, cortisol, from the adrenal cortex, as well as 128 
suppression of nonessential systems, like the digestive and immune systems, to allow more energy 129 
for emergency functions [12]. Once the threat has receded the parasympathetic nervous system 130 
returns the body to homeostasis [13]. 131 
 132 
Stress induced physiological and metabolic changes are crucial for survival in the presence of an 133 
actual present-moment threat but can have a range of negative effects when activated 134 
unnecessarily and chronically. This is because stressors can be both real and perceived, and 135 
psychological stressors such as worry about the future, anticipation, reliving the past, rumination 136 
and arousal can lead to chronic activation of the stress response, which is detrimental to health and 137 
wellbeing as it increases the risk of health problems and contributes to a wide variety of diseases, 138 
disorders and difficulties [14]. Indeed, worry and anticipation about the future and reliving the past 139 
are associated with activation of the default mode network (DMN), a large-scale network of 140 
interacting brain regions, most commonly shown to be active when the brain is at wakeful rest, 141 
when an individual is thinking about others, themselves, remembering the past, and planning for the 142 
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future [15, 16]. Alterations in the DMN activity have been associated with a number of mental 143 
health problems, including depression and anxiety [16], which are characterised by high DMN 144 
activity such as worry and rumination [17, 18].  Mindfulness practices, specifically various forms of 145 
meditation, which bring the person back to the present moment have been associated with reduced 146 
activity in the DMN [19, 20].  147 
 148 
Given the above, it is not surprising that persistent activation of the stress response is associated 149 
with the onset and maintenance of mental health issues such as anxiety and depression [14, 21, 22], 150 
perhaps resulting, at least in part, from disruption in the feedback mechanisms required to return 151 
the body to homeostasis once a threat has passed. Stress-related increases in glucocorticoid levels 152 
and the further synthesis of pro-inflammatory cytokines (small cell signalling protein molecules 153 
involved in the innate immune response and inflammation) [23] are normally regulated by a 154 
glucocorticoid negative feedback mechanism [24]. However, persistent activation of the stress 155 
response disrupts this negative feedback mechanism [24] and results in a cumulative physiological 156 
burden which can eventually contribute to the onset of disease, mental illness and poor wellbeing 157 
[14, 25, 26]. As the neuroendocrine systems regulating the stress response are involved in the 158 
regulation of mood and emotion [27], mental illnesses such as clinical anxiety and depression are 159 
associated with increased expression of stress-induced pro-inflammatory cytokines [23], that 160 
stimulate the autonomic nervous system and hyper-secretion of corticotropin-releasing hormone 161 
(CRH), and increase circulatory cortisol and the production of pro-inflammatory cytokines [23, 24, 162 
28, 29]. 163 
 164 
While the endocrine system is important in the management of stress, the effects of meditation on 165 
the functioning of the endocrine system and wellbeing have been scarcely investigated [30-32]. In 166 
regards to the impact of meditation on the human endocrine system, the hypothalamic–pituitary–167 
adrenal axis has been most widely explored.  168 
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Meditation Influences the Hypothalamic–Pituitary–Adrenal (HPA) Axis 169 
The HPA axis is a neuroendocrine system that is involved in stress regulation and various other 170 
bodily processes and plays a key role in mental health and wellbeing. The HPA axis controls the 171 
synthesis and release of stress hormones including CRH, adrenocorticotropin hormone (ACTH), and 172 
cortisol, in response to stressors. The release of CRH from the hypothalamus results in release of 173 
ACTH, which then acts on the adrenal cortex to release cortisol into the blood (Figure 1). Cortisol 174 
subsequently acts in a negative feedback fashion to terminate the continued release of CRH. 175 
Disruptions in cortisol production can result in dysregulation of the HPA axis, which has been 176 
associated with a range of mental health problems, such as depression and anxiety [32].  177 
 178 
The HPA axis has been the mostly widely studied of the endocrine systems in regards to the effects 179 
of meditation. A systematic review of 45 randomized controlled trials investigating the effects of 180 
focused attention, open monitoring and automatic self-transcending subtypes of meditation 181 
(defined in Box 1) on markers of stress, and compared to an active control group, found that focused 182 
attention, but not automatic self-transcending meditation, reduced cortisol levels [9]. In this review 183 
[9], meta-analysis to investigate the effects of open monitoring meditations, such as mindfulness 184 
meditation, was unable to be performed due to an insufficient number of trials. Previous research, 185 
however, indicates that mindfulness-based meditation may also influence HPA axis stress hormone 186 
levels, and that this is associated with improved mental health and wellbeing [33-35]. For example, 187 
in a pre-post study of 16 individuals with clinical depression and anxiety, two months of mindfulness 188 
meditation improved psychological wellbeing and increased ACTH, indicating that mindfulness 189 
meditation can enhance psychological well-being and regulate hormonal parameters [31]. In a 190 
randomized controlled trial of 150 healthy individuals, practising amrita meditation four times a 191 
week resulted in a decline in adrenaline and cortisol levels from as early as 48 hours after beginning 192 
the meditation program. The decline in adrenaline and cortisol levels was similarly present after 193 
eight months of engaging in amrita meditation four times a week, compared to progressive muscle 194 
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relaxation and a no intervention control [36]. In cross-sectional studies of regular transcendental 195 
meditation (a form of automatic self-transcending mediation) practitioners (three to five years of 196 
practice) and new transcendental meditation practitioners (three to four months of practice), the 197 
former group were associated with more marked and sustained declines in cortisol levels than the 198 
latter group [37, 38]. In a study of 34 Chinese undergraduate students, two and four weeks of 199 
integrative body-mind training, which included mindfulness training, reduced salivary cortisol levels 200 
both at rest and following a laboratory-based stress-inducing task, compared to relaxation [39]. 201 
 202 
In a pre-post study of 59 patients with early stage breast or prostate cancer, a mindfulness-based 203 
stress reduction program, which included meditation, was associated with decreased cortisol levels 204 
as well as levels of pro-inflammatory cytokines, systolic blood and stress symptoms, indicating less 205 
stress and mood disturbance [40]. In a pilot study of 30 postmenopausal women, salivary and 206 
urinary excretion of cortisol following a metabolic stressor (oral glucose consumption) was higher in 207 
16 long-term practitioners of transcendental meditation when compared with 14 non-meditators, 208 
which may reflect improved endocrine regulation in response to metabolic challenge [41]. In a 209 
randomized controlled trial of 57 patients with colorectal cancer, a single mindfulness meditation 210 
practice delivered during active chemotherapy administration resulted in increased cortisol 211 
reactivity, suggesting that mindfulness practice can reduce the blunting of neuroendocrine profiles 212 
typically observed in cancer patients and supporting the use of mindfulness in oncology [42].  These 213 
studies collectively indicate that meditation influences the regulation of the HPA axis, which may 214 












Open monitoring or mindfulness-based meditation involves non-reactive 
observation of the content of ongoing experience, to become reflectively aware 
of cognitive and emotional patterns [43, 44]. 
Focused 
attention 
In focused attention meditation, attention is focused and sustained on a particular 
object and brought back to the object when the mind has wandered. Thus, the 




AST involves a meaningless mantra that the meditator can attend to without 
effort or concentration, with the aim of the mantra becoming secondary and 
ultimately disappearing as self-awareness increases. In AST meditation the mind 
should be free from focus and mental effort [46]. 
 223 
Meditation Influences the Hypothalamic–Pituitary–Thyroid (HPT) Axis 224 
The HPT axis determines and regulates thyroid hormone production, which is vital to metabolism, 225 
nervous system development and thermogenesis, among other functions [47], and appears to be 226 
involved in the pathophysiology of anxiety [48] and depression [49]. Thyroid-stimulating hormone 227 
(TSH) controls the synthesis and release of triiodothyronine (T3) and thyroxine (T4). Plasma levels of 228 
T3 and T4 are maintained within a narrow range and too much or too little can lead to 229 
hyperthyroidism or hypothyroidism, respectively (Figure 1) [47]. There is limited scientific research 230 
regarding the effects of meditation on thyroid hormones, though the available evidence suggests 231 
that some forms of meditation may influence thyroid functioning in particular populations, as 232 
discussed below.   233 
 234 
With age, TSH levels gradually increase, possibly due to decreased biological activity of the peptide 235 
hormone, or increasing thyroid resistance to TSH. However, in long-term practitioners of 236 
transcendental meditation, TSH levels are seen to decrease [50]. This is apparent in a prospective 237 
study of 11 men who had been practising transcendental meditation for at least three years, where 238 
an advanced transcendental meditation practice (termed TM-Sidhi) was associated with a decline in 239 
TSH levels, but not in cortisol, T4 or T3 levels, indicating that transcendental meditation may effect 240 
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some, but not all, markers of neuroendocrine function [50]. In a randomized controlled trial of 49 241 
healthy Caucasian males, four months of transcendental meditation practice, 15-20 minutes twice a 242 
day, was associated with a decrease in TSH and cortisol levels and an increase in growth hormone 243 
levels, compared with stress education transcendental meditation [51]. It is possible that 244 
transcendental meditation was associated with a decrease in cortisol levels in this study as 245 
individuals were meditation naive at baseline [51], whereas in the earlier study [50], as individuals 246 
had already been practising transcendental meditation for at least three years, any changes in 247 
cortisol levels had already occurred [51]. A more recent non-randomized study of 45 healthy men 248 
and women found that a 12 week yoga program including an unspecified form of meditation 249 
increased TSH levels in men, and decreased T3 and T4 levels in both men and women, compared to 250 
a waitlist control group [52]. It is possible that a yoga program including physical postures may differ 251 
from meditation alone in terms of effects on thyroid function, as physical yogic postures can 252 
influence HPT axis function [53, 54]. This is consistent with research showing that other forms of 253 
physical activity and exercise influence HPT axis function. For example, in a study involving six 254 
rowers, three weeks of high-intensity resistance training decreased TSH and T3 levels, while three 255 
weeks of endurance training increased TSH levels [55]. In obese women, TSH levels have been 256 
shown to increase during and decrease immediately after 60 minutes of aerobic exercise, while TSH 257 
levels increase and T3 levels decrease after three months of aerobic exercise training [56].  These 258 
studies collectively suggest that meditation as well as yoga including meditation may influence TSH 259 
levels, albeit in differing ways, and perhaps that these effects may be sex-specific. This hypothesis is 260 
supported by findings that in 20 middle-aged sedentary women, an eight week yoga program that 261 
included an unspecified form of meditation did not influence TSH, T4 or T3 levels, compared to a no-262 
intervention control group [57], indicating that the yoga/meditation intervention did not influence 263 
thyroid function. In sixteen individuals (nine female) with elevated depression and anxiety 264 
symptoms, two months of mindfulness meditation practised at least three times a week similarly did 265 
not influence TSH, T3 and T4 levels, though this study did not assess males and females separately 266 
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[31]. In a pilot study of 22 women with hypothyroidism, however, six months of yoga practice four 267 
times a week, including cyclic meditation, resulted in a non-significant reduction in TSH, cholesterol, 268 
triglycerides, low density lipoprotein and high-density lipoprotein levels [58]. These results indicate 269 
that meditation may improve thyroid function in women with thyroid dysfunction more effectively 270 
than in women with normal thyroid function, or that interventions of longer duration are required in 271 
order to detect benefits following meditation interventions. In addition, it should also be noted that 272 
only those studies delivering transcendental meditation were found to decrease TSH levels, and 273 
therefore different forms of meditation may also account for the divergence in results. Overall, the 274 
limited evidence suggests that some forms of meditation may influence thyroid function, which may 275 
reflect more efficient functioning of the HPT axis, and that these effects may be sex- or population-276 
specific.  277 
 278 
[INSERT Figure 1 here] 279 
 280 
Meditation Influences the Renin-Angiotensin-Aldosterone (RAA) System 281 
The RAA system regulates blood pressure, electrolyte and fluid balance [59]. Renin is an aspartic 282 
protease protein and enzyme that converts angiotensinogen to angiotensin I. Angiotensin I is 283 
converted to angiotensin II, a potent vasoconstrictive peptide, by angiotensin converting enzyme 284 
(ACE) and acts on the adrenal resulting in the release of aldosterone, a steroid hormone that 285 
increases blood pressure by causing the kidney to retain water [59]. Angiotensin II is also an 286 
important stress hormone and increases following acute and chronic stress [60]. Given its role in 287 
stress, it is not surprising that aldosterone and renin are also associated with psychological 288 
wellbeing. In a cross sectional study of 1743 individuals, living alone in combination with depressive 289 
symptomatology was seen to be associated with increased renin and aldosterone levels, while 290 
neither living alone nor having depressive symptomatology alone were associated with changes in 291 
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renin and aldosterone levels, indicating that depressed individuals may have an activated RAA 292 
system during potentially stressful circumstances [61]. 293 
 294 
While limited, the existing evidence indicates that meditation may influence the RAA system as well 295 
as stress outcomes. For example, in a cross sectional study of eight male college students who had 296 
been practising transcendental meditation for at least two years, plasma renin activity increased 297 
during transcendental meditation, compared to a quite rest condition [62]. Interestingly these 298 
meditators had a smaller increase in cortisol following venepuncture, compared to people who were 299 
not meditators, indicating that transcendental meditation may reduce stress reactivity [62]. 300 
Similarly, a cross-sectional study of 22 healthy students who had practised transcendental 301 
meditation for 8.5 years found that, compared to 33 non-meditators, they had lower levels of 302 
aldosterone, cortisol, and excretion of the norepinephrine metabolite vanillylmandelic acid, and 303 
higher levels of the serotonin metabolite, 5-hydroxyindoleacetic acid, which corresponded with 304 
lower levels of mood disturbance and anxiety [38]. This indicates that meditation-associated 305 
changes in the RAA system correspond with improved well-being and changes in hormonal stress 306 
markers [38]. 307 
 308 
Meditation Influences Energy Homeostasis 309 
Energy homeostasis depends on the balance between energy intake and expenditure. The 310 
physiological control of energy homeostasis involves multiple mechanisms and physiological systems 311 
and organs, such as the brain and white adipose tissues [63]. The brain integrates satiety or hunger 312 
signals and regulates the insulin response of glucose metabolism, among other functions [64]. There 313 
are few existing studies exploring the influence of meditation on energy homeostasis. This review 314 




Meditation and Insulin Resistance 317 
Insulin is a peptide hormone considered to be the main anabolic hormone and is necessary for the 318 
control of blood glucose levels as it signals the liver, muscle and fat cells to uptake glucose from the 319 
blood to be used for energy [65]. A recent statement from the American Heart Association highlights 320 
that there is limited research regarding the effects of meditation on metabolism and insulin 321 
resistance [10]. 322 
  323 
In a pre-post study of 50 individuals with type II diabetes, a single session of a sitting breathing 324 
meditation was associated with reduced levels of postprandial plasma glucose and systolic and 325 
diastolic blood pressure [66], though these measures were taken directly after completing the 326 
intervention and may reflect acute rather than longer term changes. 327 
 328 
In regards to longer term interventions, in a randomized controlled trial of 103 individuals with 329 
coronary artery disease, 16 weeks of transcendental meditation was associated with improved 330 
insulin resistance (and systolic blood pressure and heart rate variability), compared to health 331 
education [67]. However, in a pre-post study of 37 individuals with (30%) and without (70%) 332 
coronary artery disease, six weeks of yoga and mindfulness meditation for 90 minutes three times a 333 
week was not associated with a significant reduction in blood glucose, lipid and C-reactive protein 334 
levels in either group [68], indicating that transcendental meditation may influence metabolism 335 
more effectively than mindfulness meditation.  336 
 337 
Meditation and Leptin 338 
Leptin is a hormone secreted by and in proportion to adipose cells and regulates energy by inhibiting 339 
hunger. Leptin plays a role in inflammatory process; specifically as increases in leptin are associated 340 
with an increase in C-reactive protein [69]. The limited data indicate that meditation does not 341 
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appear to influence leptin levels. For example, in a randomized controlled trial of 186 university 342 
faculty and staff with an elevated C-reactive protein level, and with or at risk of cardiovascular 343 
disease, a two-month workplace mindfulness program incorporating mindfulness meditation, 344 
compared to lifestyle education, was not associated with any changes in leptin [70]. Similar results 345 
were found in a randomized controlled trial of 68 African American individuals who had high 346 
metabolic system risk factors, as 12 months of consciously resting meditation, which is a sound or 347 
mantra based meditation, when compared to health education, was not associated with any 348 
changes in leptin, or any of the other inflammatory biomarkers assessed [71]. These findings are not 349 
surprising given that leptin is produced by adipocytes adipose cells and is correlated with body fat 350 
and as meditation practices are unlikely to result in losses in body fat [69].   351 
 352 
Concluding Remarks and Future Perspectives 353 
Most studies to date have explored the effect of meditation practice on the HPA axis and much 354 
more research is needed to examine other aspects of the endocrine system. Whilst it is intriguing 355 
that various meditation practices appear to induce changes in endocrine function and consequently 356 
be associated with improvements in mental health, the underlying associations and mechanisms 357 
that might operate are unclear, though likely involve psychological, physiological and neurological 358 
processes. This is hampered by a lack of definition of what meditation is and the wide variety of 359 
forms of meditation practised. Better descriptions of actual practices and robust studies of their 360 
effect are needed. Many of the studies reported have small sample sizes, appear to have insufficient 361 
statistical power to demonstrate clear effects, and fail to include an active control group [9]. Thus, 362 
prime consideration should be given to the design, conduct and reporting of rigorously controlled 363 
trials to test the effectiveness of particular types of meditation practices in delineated populations, 364 
using well described interventions and comparison groups, and appropriate measures of outcome 365 
and experience. For example, studies should make explicit characteristics such as the precise nature 366 
of the meditation practice used (e.g. type, dose, duration, content), the person practising it (e.g. 367 
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occupation, training, qualifications, experience), how and when it is practised (e.g. individual/group, 368 
audio, time) and where it is practised (e.g. home, gym, community/health centre).  For example, did 369 
the study: offer individuals a choice of or preference for a particular form of meditation; measure 370 
the level of practice (e.g. some people may have completed the course but did not practice at 371 
home); or control for other factors like diet and exercise? Was the intervention too brief or dose too 372 
small to be able to produce a meaningful therapeutic effect on, for instance, endocrine function or 373 
mental health outcomes? To illustrate, for example, the effect of duration of meditation practice on 374 
biological measures, a recent study of a single 10-minute audio-guided mindfulness meditation 375 
suggested that such practice can promote effective heart rate regulation, and thereby effective 376 
recovery, after a stressful event for individuals with tension and migraine headaches [72].  In 377 
contrast, an earlier study of group-delivered transcendental meditation for 90 minutes a day for six 378 
months, compared to health education, found no statistically significant differences in brain 379 
natriuretic peptide and cortisol levels among individuals with heart failure [73].  In addition to trials, 380 
qualitative studies are also needed to explore how meditation practices might work, taking into 381 
account contextual factors such as culture, religion and beliefs, and help untangle this complex field 382 
and explain possible mechanisms. Overall, whilst this paper suggests there is a connection between 383 
meditation, the endocrine system and health and wellbeing, the area remains underexplored and 384 
awaits better understanding.  385 
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   Figure 1. The role of the endocrine system in mediating stress 597 
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